Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record

Little is known about the difference in durability of HBsAg seroclearance induced by nucleoside analogs (NAs) or by interferon (IFN). A real-world, retrospective cohort study was conducted. Patients were assigned into two groups: NAs monotherapy-induced HBsAg seroclearance subjects and IFN monothera...

詳細記述

書誌詳細

主要な著者:	Zongqi Shi, Huizhi Zheng, Miaomiao Han, Jieli Hu, Yuan Hu, Xiaosong Li, Wenyan Zhu, Xinjun He, Haijun Deng, Quanxin Long, Ailong Huang
フォーマット:	Artigo
言語:	Inglês
出版事項:	KeAi Communications Co., Ltd. 2023-05-01
シリーズ:	Genes and Diseases
主題:	anti-HBs Chronic hepatitis B Infection Clinical outcomes after HBsAg seroclearance Durability of HBsAg seroclearance Interferon monotherapy Nucleoside analogs monotherapy
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2352304222000563
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!